RxDoctor Payments Data

Alyssa Hauff

Family · Macedonia, OHNPI 1982288627

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.3% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,768in general payments, 2019–2025

Across 216 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$701
  • AbbVie$551
  • Johnson & Johnson$319
  • Novartis$303
  • Organon$227
  • Sanofi$225
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$3,43991%
  • Education$3299%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,768 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio →

Medicare billing

Part B allowed, 2024
$96,525
Medicare patients
472
Services billed
1,971

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate109$3,883
Fluorouracil39$3,171
Triamcinolone Acetonide174$2,219
Ketoconazole120$2,046
Metronidazole41$1,707
Fluocinolone Acetonide13$708
Doxycycline Hyclate48$691
Fluocinonide15$643
Clindamycin Phosphate14$639
Mupirocin108$630
Clotrimazole36$342
ValacyclovirValacyclovir Hcl19$303
Hydrocortisone38$235
Prednisone19$58

Paid to pharmacies, not to this prescriber.

Other family in Macedonia

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →